4//SEC Filing
Yablonka Uri 4
Accession 0001144204-18-062651
CIK 0001137883other
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 5:03 PM ET
Size
5.9 KB
Accession
0001144204-18-062651
Insider Transaction Report
Form 4
Yablonka Uri
DirectorChief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2018-11-30+13,333→ 13,333 totalExercise: $0.75From: 2018-12-30Exp: 2028-11-30→ Common Stock (13,333 underlying)
Footnotes (1)
- [F1]Option vests and becomes exercisable in 12 consecutive, equal monthly installments commencing on December 30, 2018 until fully vested and exercisable on November 30, 2019, provided that the reporting person remains a director of Brainstorm Cell Therapeutics on each vesting date.
Documents
Issuer
BRAINSTORM CELL THERAPEUTICS INC.
CIK 0001137883
Entity typeother
Related Parties
1- filerCIK 0001608814
Filing Metadata
- Form type
- 4
- Filed
- Nov 29, 7:00 PM ET
- Accepted
- Nov 30, 5:03 PM ET
- Size
- 5.9 KB